WOAG
WITHDRAWAL OF ATTORNEY GRANTED
03/07/2024
Back to search
Official data from USPTO
THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT
ST13
US500000088165746Class
5
Filing
88165746
Registration
7080874
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
71
Latest update
03/07/2024
Trademark type
Word
Nice classes
5
Filing date
10/23/2018
Registration date
06/13/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2023
Last transaction
03/07/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/23/2018
First use in commerce
12/04/2021
Drawing code
4
Owner type
03
Owner location
Newport Beach, CA
Examiner
LOOK, JEFFREY
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Vivera Pharmaceuticals, Inc.
Representatives
Vivera Pharmaceuticals, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of orodispersable tablets and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations; Pain relief medication; Pharmaceutical preparations for the treatment and prevention of chronic pain; Pharmaceutical preparations for the treatment of the cardiovascular systemthe circulatory systemthe digestive systemthe excretory systemthe endocrine systemthe integumentary systemthe exocrine systemthe lymphatic systemthe immune systemthe muscular systemthe nervous systemthe renal systemthe urinary systemthe reproductive systemand/or the skeletal system; Pharmaceutical preparations for non-addictive pain management; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparationsan analgesic for human consumption taken orally; Chemical preparations for pharmaceutical or medical purposesfor non-addictive pain management; none of the foregoing items comprised of Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) content of more than 0.3 percent on a dry weight basis and none of which are comprised of cannabidiol (CBD)
Publications
History of USPTO decisions and trademark events.
71 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
03/07/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/13/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/11/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/10/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/14/2023
DOCK
ASSIGNED TO EXAMINER
03/13/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/13/2023
PBMR
WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
03/13/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2023
ALIE
ASSIGNED TO LIE
01/24/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/25/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/25/2022
GNRT
NON-FINAL ACTION E-MAILED
05/25/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
05/25/2022
DOCK
ASSIGNED TO EXAMINER
05/05/2022
DOCK
ASSIGNED TO EXAMINER
03/29/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/25/2022
IUAF
USE AMENDMENT FILED
03/23/2022
EISU
TEAS STATEMENT OF USE RECEIVED
03/23/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/15/2021
EX5G
SOU EXTENSION 5 GRANTED
10/14/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/14/2021
EXT5
SOU EXTENSION 5 FILED
10/11/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/11/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/20/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/09/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/27/2021
EX4G
SOU EXTENSION 4 GRANTED
04/23/2021
EXT4
SOU EXTENSION 4 FILED
04/23/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/23/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/19/2020
EX3G
SOU EXTENSION 3 GRANTED
12/18/2020
NREV
NOTICE OF REVIVAL - E-MAILED
12/11/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
12/11/2020
PETG
PETITION TO REVIVE-GRANTED
12/11/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
12/11/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
11/23/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
11/23/2020
EXT3
SOU EXTENSION 3 FILED
10/23/2020
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
10/08/2020
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
10/08/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/06/2020
EX2G
SOU EXTENSION 2 GRANTED
10/05/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/05/2020
NREV
NOTICE OF REVIVAL - E-MAILED
08/11/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
08/10/2020
PETG
PETITION TO REVIVE-GRANTED
08/10/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
08/10/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
06/08/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
06/08/2020
EXT2
SOU EXTENSION 2 FILED
04/23/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/13/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/13/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/18/2019
EX1G
SOU EXTENSION 1 GRANTED
10/16/2019
EXT1
SOU EXTENSION 1 FILED
10/16/2019
EEXT
SOU TEAS EXTENSION RECEIVED
10/16/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/23/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/22/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/22/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/26/2019
PUBO
PUBLISHED FOR OPPOSITION
02/26/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/17/2019
DOCK
ASSIGNED TO EXAMINER
01/15/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/04/2018
NWAP
NEW APPLICATION ENTERED
10/26/2018
Continuous trademark protection
Get notified about every new filing that threatens THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.